Stock listing
Curanex Pharmaceuticals Inc
Selected listing: CURX · NASDAQ · USD · US
Curanex Pharmaceuticals Inc (NASDAQ:CURX), Health Technology. Latest release Apr 2, 2026: Curanex Expands Its Drug Development Pipeline to Include Cancer…
- Ticker
- NASDAQ:CURX
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- Exchange
- NASDAQ
- Currency
- USD
About Curanex Pharmaceuticals Inc
The company focuses on developing pharmaceutical products, contributing to advancements in healthcare. Investors can find information about Curanex and its activities on the 6ix platform.
Latest news from Curanex Pharmaceuticals Inc
Curanex Expands Its Drug Development Pipeline to Include Cancer Cachexia, Representing a Multi-Billion-Dollar Market Opportunity and Important Step In The Company’s Evolution Into a Broader Therapeutics Development Company
April 1, 2026
Curanex Provides Business Update in Connection with 2025 Annual Report as Phyto-N Advances Toward Planned IND Submission
March 29, 2026
Curanex Achieves Key Preclinical Milestone with Favorable Toxicology Profile at Maximum Dose, Advancing Toward IND Submission
March 17, 2026
Curanex Expands Scientific Advisory Board With Two Distinguished Researchers
March 11, 2026
Curanex Appoints Two Veteran Industry Leaders to Scientific Advisory Board
March 10, 2026
Research Curanex Pharmaceuticals Inc
Curanex Pharmaceuticals Inc company profile
View the public company page for Curanex Pharmaceuticals Inc on 6ix.
Curanex Pharmaceuticals Inc news
Read company news and market updates connected to Curanex Pharmaceuticals Inc.
Curanex Pharmaceuticals Inc investor events
Find investor webinars, events, and replay context for Curanex Pharmaceuticals Inc.